Scholarlink

Purpose <p>This study aimed to evaluate the feasibility and safety of treating myofascial pain syndrome (MPS) with the ultrasound-guided myofascial hydrodissection technique (UMHT) to assess the efficacy of UMHT in alleviating pain and improving functional capacity among patients with MPS, contributing to the ongoing discourse regarding optimal treatment options for this condition.</p> Methods <p>This retrospective cohort study was conducted at a clinical research institution affiliated with a university. This study enrolled 28 individuals diagnosed with MPS, who received one session of UMHT weekly. Pain severity and functional parameters were assessed at baseline, 24&#xa0;h, 2 weeks, 1 month, and 3 months post-treatment using the Visual Analogue Scale (VAS), McGill Pain Questionnaire, and Oswestry Disability Index (ODI), respectively.</p> Results <p>We observed a significant reduction in pain, as evidenced by improvements in VAS (χ² = 60.63, <i>p</i> &lt; 0.01) and McGill scores (χ² = 57.31, <i>p</i> &lt; 0.01). Additionally, we observed functional improvement, with a significant reduction in ODI scores (χ² = 55.66, <i>p</i> &lt; 0.0001). No adverse events were reported throughout the study.</p> Conclusion <p>UMHT significantly reduced pain and improved functional capacity in patients with MPS. These findings suggest that UMHT is a promising and safe treatment for MPS, although further research is needed to confirm its long-term efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Ultrasound-Guided Myofascial Hydrodissection for Myofascial Pain Syndrome: A Retrospective Study on Pain Relief and Functional Improvement

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Yongjia Chen,
  • Yannan Sun,
  • Shaolong Ai,
  • Hongchen He,
  • Qian Wang

摘要

Purpose

This study aimed to evaluate the feasibility and safety of treating myofascial pain syndrome (MPS) with the ultrasound-guided myofascial hydrodissection technique (UMHT) to assess the efficacy of UMHT in alleviating pain and improving functional capacity among patients with MPS, contributing to the ongoing discourse regarding optimal treatment options for this condition.

Methods

This retrospective cohort study was conducted at a clinical research institution affiliated with a university. This study enrolled 28 individuals diagnosed with MPS, who received one session of UMHT weekly. Pain severity and functional parameters were assessed at baseline, 24 h, 2 weeks, 1 month, and 3 months post-treatment using the Visual Analogue Scale (VAS), McGill Pain Questionnaire, and Oswestry Disability Index (ODI), respectively.

Results

We observed a significant reduction in pain, as evidenced by improvements in VAS (χ² = 60.63, p < 0.01) and McGill scores (χ² = 57.31, p < 0.01). Additionally, we observed functional improvement, with a significant reduction in ODI scores (χ² = 55.66, p < 0.0001). No adverse events were reported throughout the study.

Conclusion

UMHT significantly reduced pain and improved functional capacity in patients with MPS. These findings suggest that UMHT is a promising and safe treatment for MPS, although further research is needed to confirm its long-term efficacy.